Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-023-02146-y.pdf
Reference115 articles.
1. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. Epub 2021/04/06. https://doi.org/10.1002/ijc.33588. PubMed PMID: 33818764.
2. Labanieh L, Majzner RG, Mackall CL. Programming CAR-T cells to kill cancer. Nat Biomed Eng. 2018;2(6):377–91. Epub 2019/04/24. https://doi.org/10.1038/s41551-018-0235-9. PubMed PMID: 31011197.
3. Sadelain M, Brentjens R, Riviere I. The basic principles of chimeric antigen receptor design. Cancer Discov. 2013;3(4):388–98. Epub 2013/04/04. https://doi.org/10.1158/2159-8290.CD-12-0548. PubMed PMID: 23550147; PubMed Central PMCID: PMCPMC3667586.
4. Guedan S, Calderon H, Posey AD, Jr., Maus MV. Engineering and design of chimeric antigen receptors. Mol Ther Methods Clin Dev. 2019;12:145–56. Epub 2019/01/23. https://doi.org/10.1016/j.omtm.2018.12.009. PubMed PMID: 30666307; PubMed Central PMCID: PMCPMC6330382.
5. Maude SL, Teachey DT, Porter DL, Grupp SA. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood. 2015;125(26):4017–23. Epub 2015/05/23. https://doi.org/10.1182/blood-2014-12-580068. PubMed PMID: 25999455; PubMed Central PMCID: PMCPMC4481592.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The evolution and ongoing challenge of unproven cell-based interventions;Stem Cells Translational Medicine;2024-07-23
2. CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up;International Immunopharmacology;2024-06
3. CAR-T Cell Therapy for Cancer;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-04-15
4. MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV;Retrovirology;2024-02-29
5. Tagging CAR-T cells to enable control and quantitative imaging;Molecular Therapy;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3